Search the Newsreel

Charles River Laboratories International (NYSE:CRL) Upgraded by JPMorgan Chase & Co. to "Overweight" Rating

JPMorgan Chase & Co. upgraded Charles River Laboratories International (NYSE:CRL) to an "overweight" rating from "neutral" and significantly raised its price target to $310 from $180, suggesting a 19.18% upside. This upgrade follows Charles River's strong second-quarter performance, where it surpassed EPS and revenue …

Charles River Laboratories (NYSE: CRL) insider plans Rule 144 sale of RSU and option shares

An insider at Charles River Laboratories (NYSE: CRL) plans to sell 4,300 shares from Restricted Stock Units (RSUs) and Performance Stock Units (PSUs) granted in 2022, along with 2,345 shares from a stock option exercise. The anticipated sale date is August 6, 2026, with …

Charlton Aria Acquisition Corp 2Q 2026: Net income $567766 EPS $0.05— 10-Q Summary

Charlton Aria Acquisition Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

Charles River Laboratories , Inc. Stock 12‑Month Price Target Raised to $277.92, Implies 7% Upside

Analysts have raised the 12-month average price target for Charles River Laboratories International, Inc. (CRL) stock from $274.85 to $277.92, indicating a 7% potential upside from its August 5th closing price. The consensus rating among 19 analysts remains "Buy," with 14 recommendations for Buy, …

Charles River Labs (CRL) CEVP sells 5,046 shares under 10b5-1 plan

Shannon M. Parisotto, CEVP of Discovery & Safety Assessment at Charles River Laboratories International, Inc. (CRL), sold 5,046 shares of common stock at $263.00 per share on August 5, 2026. This transaction was conducted under a Rule 10b5-1 Trading Plan established on March 4, …

Harley-Davidson (HOG) Reports Weaker Earnings, Is The Stock Fully Priced?

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. SEC Filing (Aug 6, 2026)

This article details an SEC Form 144 filing by CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) on August 6, 2026. The filing indicates a proposed sale of 4,179 shares of common stock acquired through a stock option exercise, with an aggregate market value of $1,086,540, …

Charles River Laboratories International Q2 Earnings Call Highlights

Charles River Laboratories International (CRL) exceeded Q2 expectations, driven by improved demand in its Discovery and Safety Assessment (DSA) business and strong manufacturing performance. The company raised its full-year guidance for revenue, earnings, and free cash flow, anticipating a gradual recovery in biopharmaceutical demand. …

CHARLES SCHWAB CORP CHARLES SCH (0L3I.L) Q1 FY2026 earnings call transcript

Charles Schwab reported record Q1 2026 results, with revenue up 16% year-over-year to $6.5 billion and adjusted EPS reaching $1.43, a 38% increase. The company attributed this outperformance to strong client engagement, robust asset gathering, and expanding lending. Management indicated that EPS is tracking …

FMR LLC reports 8.8% ownership of Charles River (CRL) common stock

FMR LLC has disclosed an 8.8% beneficial ownership stake in Charles River Laboratories International, Inc. (CRL) common stock as of June 30, 2026. This translates to 4,239,751.47 shares, with FMR LLC exercising sole voting power over 4,190,715.80 shares and sole dispositive power over all …

Here Are Thursday’s Top Wall Street Analyst Research Calls: AppLovin, Charles River, Global Payments, HubSpot, Insulet Corporation, Roper Technologies, Sabra Health Care, Western Digital, Zillow Group, and More

This article details Thursday's top Wall Street analyst research calls, including upgrades, downgrades, and new initiations for various companies like Charles River Laboratories, Global Payments, AppLovin, and HubSpot. It also provides a snapshot of the market on Wednesday, noting mixed futures, a strong Dow …

Is Schwab Fundamental U.S. Small Company ETF (FNDA) a Strong ETF Right Now?

The Schwab Fundamental U.S. Small Company ETF (FNDA) is highlighted as a strong smart beta ETF for investors seeking exposure to the Style Box - Small Cap Value segment. The article details FNDA's fund sponsor, index, expense ratio, top holdings, and performance, noting its …

Should Schwab U.S. Large-Cap Value ETF (SCHV) Be on Your Investing Radar?

The article analyzes the Schwab U.S. Large-Cap Value ETF (SCHV), highlighting its low expense ratio, significant assets under management, and strong performance. It targets investors seeking exposure to large-cap value stocks and notes its diversification benefits and "Strong Buy" Zacks ETF Rank. The piece …

Sei Investments Co. Purchases 114,441 Shares of Harley-Davidson, Inc. $HOG

Sei Investments Co. increased its stake in Harley-Davidson, Inc. (NYSE:HOG) by 100.8% in the first quarter, purchasing an additional 114,441 shares, bringing its total holdings to 228,009 shares valued at $4.6 million. Other institutional investors also adjusted their positions, and insider activity included a …

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. 2026: Revenue $1B, EPS ($0.03) — 10-Q Summary

Charles River Laboratories International, Inc. reported Q3 2026 results, with revenue of $1 billion and a diluted EPS loss of ($0.03), reflecting a 2.7% year-over-year decline in revenue and a significant drop in net income. The company is implementing cost-saving measures and restructuring actions …

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. : BAIRD RAISES TARGET PRICE TO $291 FROM $255

Baird has increased its target price for Charles River Laboratories International, Inc. (CRL.N) from $255 to $291. This update reflects a positive outlook from the analytical firm regarding the company's financial prospects. The news was reported by Reuters.

Charles River Laboratories International, Inc. reports results for the quarter ended June 30 - Earnings Summary

Charles River Laboratories International, Inc. has released its earnings summary for the quarter that concluded on June 30. The article, sourced from Reuters, provides a brief announcement of these results. Readers can access the full report and more news on TradingView.

ETFs Investing in Charles Schwab Corp Depositary Shs Repr 1/40th 5.95 % Non-Cum Pfd Shs Series D Stocks

This article lists various ETFs that hold Charles Schwab Corp Depositary Shares, specifically the 5.95% Non-Cumulative Perpetual Preferred Stock, Series D (SCHW/PD). It provides a detailed table including each ETF's market value, weight of SCHW/PD, issuer, management style, expense ratio, AUM, price, change, relative …

Harley-Davidson (NYSE:HOG) CFO Jonathan Root Sells 1,554 Shares of Stock

Harley-Davidson CFO Jonathan Root sold 1,554 shares of company stock for approximately $38,664 under a pre-arranged trading plan, reducing his ownership by 5.29%. This transaction occurred as Harley-Davidson's shares fell 1.1% to $26.21, despite the company exceeding Q2 earnings and revenue estimates. The company …

Harley-Davidson Director Nova Buys 40,000 Shares for $983,000. What Does This Say About HOG's Prospects in 2026?

Daniel J. Nova, Director of Harley-Davidson, Inc. (NYSE:HOG), purchased 40,000 shares of common stock on July 31, 2026, according to a recent SEC Form 4 filing. Transaction summary Metric Value Transaction value $982,800 Shares purchased 40,000 Post-transaction shares (directly held) 47,605 Post-transaction value ~$1.17 …

Harley-Davidson (NYSE: HOG) CFO trades 1,554 shares under 10b5-1 plan

Harley-Davidson's CFO and CCO, Jonathan R. Root, sold 1,554 shares of Common Stock on August 3, 2026, at a weighted average price of $24.8802 per share. This sale was conducted under a Rule 10b5-1(c) trading plan adopted on February 17, 2026. Following the transaction, …

Charles River Laboratories International (NYSE:CRL) Posts Earnings Results, Beats Expectations By $0.28 EPS

CRL (CRL) insider files Form 144 for potential 5,046-share sale

An insider at Charles River Laboratories International, Inc. (CRL) has filed a Form 144, indicating a potential sale of up to 5,046 common shares on the NYSE, with an aggregate market value of $1,327,098.00. The shares, which represent a small portion of the 47,738,872 …

Charles Schwab insider plans 11,050-share sale in Form 144 filing (GFF)

Brian G. Harris has filed a Form 144 to sell 11,050 shares of The Charles Schwab Corporation (SCHW) common stock, with a proposed sale date of August 5, 2026, on the NYSE. These shares are related to RSU awards from December 2023. This filing …

Harley-Davidson-controlled electric motorcycle maker LiveWire faces NYSE delisting

LiveWire, the electric motorcycle company controlled by Harley-Davidson, is facing delisting from the NYSE because its shares have traded below $1 for an extended period. The company has stated its intention to address and cure this deficiency. This development follows previous articles discussing analysts' …

Charles River Laboratories Stock Rallies As Analysts Hike Targets

Charles River Laboratories International Inc. (NYSE: CRL) stock rallied by 10.96% following positive institutional demand and analyst upgrades, with several major banks raising their price targets. The company's Q2 2026 earnings release, set for August 5, 2026, is a key near-term catalyst, with traders …

Four Rivers Harley-Davidson sells to Steven Towers

Performance Brokerage Services announced the sale of Four Rivers Harley-Davidson to Steven Towers, marking Towers' seventh Harley-Davidson dealership and first in Kentucky. The dealership will be rebranded as Towers' Bourbon Barrel Harley-Davidson. The previous owners, Eddy Soberon and Eric Sternberg, sold the dealership after …

Schwab Charles Insider Sold Shares Worth $15,104,987, According to a Recent SEC Filing

An insider at Charles Schwab recently sold a significant amount of company stock. According to an SEC filing, the insider disposed of shares valued at over $15 million. This transaction provides insight into insider activity at the financial services company.

The Charles Schwab Corporation (SCHW) insiders file Form 144 for stock sales

The Charles Schwab Corporation (SCHW) insiders have filed a Form 144, signaling their intent to sell restricted or control shares. The filing indicates plans to sell 1,999,016 shares, with the issuer having 1,739,135,507 common shares outstanding. It also details past transactions, including a gift …

Charles River Laboratories International Up Nearly 12%, on Track for Highest Close Since April 2024 -- Data Talk

Charles River Laboratories International (CRL) is experiencing a significant surge, with its stock up nearly 12% and on track for its highest close since April 1, 2024. The company's stock is currently trading at $262.05, marking a 31.37% increase year-to-date and making it the …

Charles River Laboratories stock hits 52-week high at $266.00 By Investing.com

Charles River Laboratories International Inc. (CRL) stock reached a new 52-week high of $266.00, surpassing its previous high of $242.73, and now boasts a market capitalization of $11.28 billion. This surge reflects a 39.78% price return over the past year and a 27.45% gain …

Charles Schwab (SCHW) executive files notice to sell 56,740 common shares

Jonathan M. Craig, an executive at The Charles Schwab Corporation (SCHW), has filed a Form 144 notice indicating a proposed sale of 56,740 common shares on August 5, 2026. This sale is related to a stock option exercise. The filing also notes a previous …

GAMMA Investing LLC Grows Position in The Charles Schwab Corporation $SCHW

GAMMA Investing LLC has increased its stake in The Charles Schwab Corporation (NYSE:SCHW) by 20.5% in Q2, bringing its total holdings to 55,827 shares valued at $5.15 million. This comes as Charles Schwab reported strong Q2 earnings, beating revenue and EPS estimates, with institutional …

Charles River Laboratories International, Inc. 2026 Q2 - Results - Earnings Call Presentation (NYSE:CRL) 2026-08-05

Charles River Laboratories International (CRL) exceeded Q2 expectations, driven by improved demand in its Discovery and Safety Assessment (DSA) business and strong manufacturing performance. The company raised its full-year guidance for revenue, earnings, and free cash flow, anticipating a gradual recovery in biopharmaceutical demand. …

Charles Schwab stock hits all-time high at 107.54 USD

Charles Schwab (SCHW) stock has reached an all-time high of $107.54, trading just below its 52-week high. The company has shown robust performance with an 11.67% increase over the past year and year-to-date gains of 7.19%, driven by strong quarterly earnings and positive analyst …